Cellebrite DI Ltd.
CLBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,614,668 | $1,646,738 | $796,543 | $1,154,899 |
| - Cash | $191,659 | $189,517 | $87,645 | $145,973 |
| + Debt | $10,969 | $14,129 | $15,356 | $0 |
| Enterprise Value | $4,433,978 | $1,471,350 | $724,254 | $1,008,926 |
| Revenue | $401,203 | $325,110 | $270,651 | $246,246 |
| % Growth | 23.4% | 20.1% | 9.9% | – |
| Gross Profit | $338,610 | $271,879 | $219,905 | $203,689 |
| % Margin | 84.4% | 83.6% | 81.3% | 82.7% |
| EBITDA | $67,513 | -$64,799 | $130,103 | $89,465 |
| % Margin | 16.8% | -19.9% | 48.1% | 36.3% |
| Net Income | -$283,007 | -$81,100 | $120,805 | $71,396 |
| % Margin | -70.5% | -24.9% | 44.6% | 29% |
| EPS Diluted | -1.35 | -0.43 | 0.59 | 0.44 |
| % Growth | -214% | -172.9% | 34.1% | – |
| Operating Cash Flow | $132,171 | $102,058 | $20,577 | $36,052 |
| Capital Expenditures | -$10,609 | -$7,918 | -$9,085 | -$8,111 |
| Free Cash Flow | $121,562 | $94,140 | $11,492 | $27,941 |